false
OasisLMS
Catalog
2021 Annual Meeting Knee Access Pass
Questions and Answers: Session B: Meniscus
Questions and Answers: Session B: Meniscus
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video features a panel discussion with Dr. Gershoff and other authors regarding a series of papers on meniscal implantation. Dr. Gershoff discusses the reoperation rate mentioned in the paper, noting that it was high but can be attributed to factors such as surgical technique improvements and patient non-compliance. He also mentions revisions in the design and technique of the implant, indicating that revisions in technique have been made. The panel also discusses activity restrictions after implantation and the potential introduction of the implant in the United States, awaiting FDA approval. The cost is uncertain at the moment. The conversation then shifts to the possibility of meniscus tibial ligament repair and addressing residual extrusion. The limitations of data from the Kaiser system are acknowledged, and indications for root repair are discussed, considering the better outcomes compared to non-op or partial meniscectomy. Overall, the video provides insights into the reoperation rate, technique improvements, activity restrictions, FDA approval process, and the potential future directions for meniscal implantation.
Asset Caption
Daniel Kaplan, MD; Mario Hevesi, MD; David Ding, MD; William Cregar, MD; Wayne Gersoff, MD
Keywords
meniscal implantation
reoperation rate
surgical technique improvements
FDA approval
root repair
×
Please select your language
1
English